At five years following RT, survival rates for men who received
brachytherapy alone were comparable to those who underwent more aggressive radiation treatment.
«Intermediate risk prostate cancer may be well controlled with
brachytherapy alone.»
Patients were randomized to one of two treatment arms, where 292 patients received
brachytherapy alone (the B group) and 287 patients received 45 Gy partial EBT to the pelvic area in addition to brachytherapy (the EBT+B group).
«Contrary to expectations, the more aggressive, combined treatment did not result in superior cancer control rates at five years follow - up, indicating that men can achieve a similar survival benefit with fewer late side effects through
brachytherapy alone.»
Not exact matches
In terms of patient survival,
brachytherapy was associated with a higher four - year cause - specific survival (64.3 percent vs. 51.5 percent) and overall survival (58.2 percent vs. 46.2 percent) compared to EBRT
alone.
Of the 7,359 patients identified, the researchers found that 63 percent of these women received
brachytherapy in combination with EBRT, and 37 percent received EBRT
alone.